Table 6 Summary of health outcome measures
From: Duloxetine in the treatment of major depressive disorder: an open-label study
| Â | Baseline, mean (SD) | Endpoint, mean (SD) | p-valuea |
|---|---|---|---|
Quality of Life in Depression Scale (n = 385) | 19.0 (7.7) | 8.2 (8.7) | T = -22.6, df = 384, p < .001 |
Sheehan Disability Scale | Â | Â | Â |
   Total (n = 419) | 18.7 (5.6) | 9.5 (7.8) | T = -22.9, df = 418, p < .001 |
   Work (n = 315) | 5.7 (2.5) | 3.0 (2.8) | T = -15.6, df = 314, p < .001 |
   Social life (n = 419) | 6.6 (2.3) | 3.3 (2.9) | T = -22.1, df = 418, p < .001 |
   Family life (n = 420) | 6.3 (2.3) | 3.2 (2.8) | T = -19.5, df = 419, p < .001 |